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Abstract
Background: This study aimed at providing insight in the
frequency, emotional impact and nature of daily hassles,
experienced by patients suffering from chronic fatigue
syndrome (CFS) and/or fibromyalgia (FM), compared
with patients with a chronic organic disease. Methods:
One hundred and seventy-seven CFS/FM patients, 26
multiple sclerosis (MS) and 26 rheumatoid arthritis (RA)
patients were investigated within 2–6 months after diag-
nosis. All patients completed a self-report questionnaire
assessing daily hassles and associated distress, a visual
analogue scale assessing fatigue and pain and a depres-
sion and anxiety questionnaire. Results: CFS/FM patients
show a higher frequency of hassles, higher emotional
impact and higher fatigue, pain, depression and anxiety
levels compared with MS/RA patients. Three hassle
themes dominate in the CFS/FM group: dissatisfaction
with oneself, insecurity and a lack of social recognition.
In contrast, hassles reported by MS/RA patients show a
much larger diversity and are not focused on person-
dependent problems. Conclusions: Patients recently
diagnosed as suffering from CFS and/or FM are highly
preoccupied and distressed by daily hassles that have a
severe impact on their self-image, as well as their per-
sonal, social and professional functioning. An optimal
therapeutic approach of CFS and FM should take account
of this heavy psychosocial burden, which might refer to
core themes of these patients’ illness experience.
Copyright © 2002 S. Karger AG, Basel
Introduction
Chronic fatigue syndrome (CFS) and fibromyalgia
(FM) still remain ill-defined and badly understood condi-
tions, characterised by physical and mental fatigue, dif-
fuse muscle and joint pain, effort intolerance, headache,
sleep disturbances and signs of mild immunological dys-
function [1, 2]. Symptoms and non-symptomatic charac-
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teristics of both illnesses are thought to be largely overlap-
ping [3–5], although their pathophysiological basis may
differ [6].
It has been hypothesised, from a psychological as well
as from a neurobiological point of view, that the syn-
dromes may be ‘stress related’ [7–9]. This hypothesis is,
on the one hand, based on the fact that negative life events
(often combined with a viral infection or a physical trau-
ma) [10–13], victimisation experiences [14, 15] and the
mental or physical stress of an overactive lifestyle [16, 17]
have been found to be frequently associated with the
development of CFS/FM. On the other hand, there is
ample evidence that CFS and FM patients are confronted
with severe psychosocial stress related to coping and
adaptation problems, a lack of comprehension by the
environment and uncertainties surrounding the nature
and prognosis of their condition [18–21].
Interestingly, negative life events have been found to
exacerbate CFS symptoms [22] and worsen the prognosis
of FM [23]. This suggests that antecedent psychosocial or
physical stress could increase vulnerability for subsequent
(reactive or other) stressors, which in turn could influence
disease activity and/or disability [7–9].
Furthermore, neurobiological investigations have re-
peatedly shown hypothalamo-pituitary-adrenal axis func-
tioning to be perturbed in CFS as well as FM, implying a
lack of reactivity of this axis and resulting in decreased
cortisol secretion [24–26].
Finally, psychosocial stress may not only be linked
with major life events, but with minor events as well. Such
‘daily hassles’ or ‘everyday problems’ can cause consider-
able worry and concern and, by their chronic and accumu-
lating character, may be as stressful as a major negative
event [27]. In FM patients, higher levels of daily hassles
have been found compared with rheumatoid arthritis
(RA) patients and pain-free controls [28, 29]. To the best
of our knowledge, however, this type of chronic life stress
has not yet been empirically investigated in CFS.
In the present study, we evaluated the frequency, emo-
tional impact and nature of daily hassles, as well as
fatigue, pain, depression and anxiety experienced by
recently diagnosed CFS and FM patients. Data of the
CFS/FM group were compared with those of a control
group consisting of recently diagnosed multiple sclerosis
(MS) and RA patients, i.e., two well-defined organic con-
ditions that are characterised by chronic fatigue and pain
as well. Frequency and emotional impact of hassles were
additionally calculated for women and men.
Materials and Methods
Subjects and Setting
Participants were recruited from a multidisciplinary clinic for
patients with chronic fatigue and/or widespread pain belonging to the
departments of General Internal Medicine and Rheumatology of the
University Hospital Leuven, Belgium.
The experimental group consisted of 177 consecutive patients
(149 women and 28 men) meeting the Fukuda criteria for CFS [30]
and/or the ACR criteria for FM [31]. One hundred and ten patients
received ‘CFS’ as a primary diagnosis, while 67 were diagnosed as
suffering from ‘FM’; however, since about 80% of the patients ful-
filled both sets of diagnostic criteria, we decided to consider the two
groups together.
The control group consisted of 26 MS and 26 RA patients (41
women and 11 men), consulting at the National Multiple Sclerosis
Clinic and the Rheumatology Department of our hospital, respec-
tively. All control patients complained of fatigue and pain, but
showed no visible signs of disease. The latter inclusion criterion was
intended to make the experimental and the control group as compa-
rable as possible with regard to physical functioning, and avoid dif-
ferences in social contacts due to overt disease characteristics.
CFS/FM patients were investigated during a consultation that
took place within 2 months after the diagnosis was made. MS/RA
patients were investigated within 6 months after diagnosis. They all
filled in a visual analogue scale measuring fatigue and pain, as well as
the ‘Everyday Problem Checklist’ (EPCL), the Beck Depression
Inventory (BDI) and the State Trait Anxiety Inventory (STAI) self-
report questionnaires (see below).
Mean symptom duration was assessed via the patients’ medical
records. It was 35.5 months in CFS/FM patients (SD = 44.1) and 50.4
months in MS/RA patients (SD = 49.1), which is significantly differ-
ent, t(227) = 2.09; p = 0.038. Patient characteristics are summarised
in table 1.
Psychometric Instruments
Daily hassles were assessed using the EPCL, a Dutch self-report
questionnaire which has been proved to be sufficiently reliable and
valid [32]. The questionnaire, containing 114 items, focuses on a
large diversity of common life problems, with regard to personal
functioning, family life, social life, housing conditions, finances, pro-
fessional life, confrontations, social developments and general stress
situations. The questions have to be answered by ‘yes’ or ‘no’, and the
associated distress (or emotional impact) can be indicated on a scale
from 0 to 3.
The EPCL questionnaire provides scores on three frequency sub-
scales, i.e., general frequency (FREQ), frequency of person-depen-
dent problems (DEP-FREQ) and frequency of person-independent
problems (INDEP-FREQ); in the same vein, there are three total dis-
tress scores (TOT, DEP-TOT and INDEP-TOT), and three mean
intensity per item scores (INT, DEP-INT and INDEP-INT).
Depression was assessed by the BDI [33], and anxiety by the
STAI [34].
Data Analysis
Descriptive statistics, frequency analyses and statistical tests were
performed using SAS [35]. For the comparison of means between the
two groups, separate-variance and pooled-variance Student t tests
were performed. For the tests of association between categorical vari-
ables, ¯2 tests were used and Cramér contingency coefficients (C)
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Table 1.  Characteristics of the CFS/FM and MS/RA patient groups
CFS/FM MS/RA p
Number of patients 177 52
Gender (m/f), % 16/84 21/79 n.s.
Mean age, years 37.8 (8.6) 40.4 (9.4) n.s.
Unemployed, % 14 8 n.s.
Housewife, % 19 13 n.s.
Blue collar, % 30 27 n.s.
White collar, % 37 52 n.s.
Single/with partner, % 18/82 21/79 n.s.
Having children (yes/no), % 68/32 62/38 n.s.
Mean duration of symptoms,
months 35.5 (44.1) 50.4 (49.1) !0.05
The figures in parentheses are SD.
were calculated [36]. In order to obtain optimal statistical power for
answering our main research question, the data for the MS and RA
group were pooled. Three-group analyses of variance confirmed that




The CFS/FM group significantly differs from the MS/
RA group on nearly all EPCL subscales. As can be seen in
table 2, CFS/FM patients report a statistically significant-
ly larger number of daily hassles in general, as well as for
the person-dependent and the person-independent hassles
separately (p ! 0.05). For each of these variables, the
accompanying total distress and mean intensity per item
scores are also significantly higher for the CFS/FM pa-
tients, with the exception of the mean intensity per item
scores for the person-independent hassles where there was
no statistically significant difference between CFS/FM
and MS/RA patients [t(227) = 0.58, p = 0.5625 two-
tailed].
With regard to somatic symptoms, fatigue and pain
show higher mean levels in CFS/FM patients than in MS/
RA patients [t(227) = 11.85, p ! 0.0001 and t(227) = 6.49,
p ! 0.0001, respectively] (table 3).
With regard to affective symptoms, CFS/FM patients
are more depressed [t(227) = 6.19, p ! 0.0001] and show
more state anxiety [t(227) = 4.39, p ! 0.0001] and trait
anxiety [t(227) = 4.42, p ! 0.0001] than MS/RA patients
(table 3).
Table 2. Comparison of mean EPCL subscale scores between CFS/
FM and MS/RA patients
CFS/FM MS/RA t
FREQ mean 28.4 (16.7) 20.7 (14.7) 2.97**
DEP-FREQ mean 7.1 (4.6) 5.0 (4.3) 3.04**
INDEP-FREQ mean 5.0 (3.3) 4.0 (2.4) 2.04*
TOT mean 50.3 (36.9) 29.3 (25.5) 4.67***
DEP-TOT mean 13.1 (10.0) 6.8 (7.2) 4.23***
INDEP-TOT mean 8.2 (7.1) 5.9 (4.4) 2.79**
INT mean 1.7 (0.6) 1.4 (0.5) 3.60***
DEP-INT mean 1.7 (0.8) 1.2 (0.8) 4.12***
INDEP-INT mean 1.5 (0.8) 1.4 (0.7) 0.58 n.s.
The figures in parentheses are SD.
* p ! 0.05, ** p ! 0.01, *** p ! 0.001.
Table 3. Comparison of mean scores of fatigue, pain and affective
symptoms between CFS/FM and MS/RA patients
CFS/FM MS/RA t
Fatigue mean 7.5 (1.1) 5.3 (1.6) 11.85****
Pain mean 5.7 (2.7) 3.0 (2.4) 6.49****
BDI mean 18.0 (8.8) 9.6 (7.9) 6.19****
STAI-State mean 47.0 (13.4) 37.6 (14.1) 4.39****
STAI-Trait mean 47.6 (10.8) 40.1 (10.6) 4.42****
The figures in parentheses are SD.
**** p ! 0.0001.
It can additionally be mentioned that female CFS/FM
patients score higher than male patients on nearly all
EPCL subscales (p ! 0.05), with the exception of the mean
intensity per item subscales (table 4). This is in accor-
dance with similar sex differences found in a healthy pop-
ulation and other clinical populations [32].
Qualitative Group Comparisons
Looking into more detail to FREQ scores of the EPCL
scale, the following person-dependent items are men-
tioned by more than 50% of the CFS/FM patients: ‘you
failed to accomplish tasks that you thought you were capa-
ble of doing’, ‘your sleep was disturbed’, ‘you were in a state
of insecurity’, ‘certain people did not consider your feel-
ings’ and ‘something brought back unpleasant memories’.
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Table 4. Comparison of mean EPCL subscale scores between female







FREQ mean 29.8 (17.3) 20.9 (10.6) 2.63**
DEP-FREQ mean 7.5 (4.8) 5.0 (3.0) 2.66** 
INDEP-FREQ mean 5.2 (3.5) 3.7 (1.8) 2.21*
TOT mean 53.7 (38.1) 32.9 (23.4) 2.79**
DEP-TOT mean 13.9 (10.4) 8.9 (6.3) 2.48*
INDEP-TOT mean 8.8 (7.5) 5.0 (3.5) 2.62**
INT mean 1.7 (0.6) 1.5 (0.5) 1.66 n.s.
DEP-INT mean 1.8 (0.8) 1.5 (0.8) 1.82 n.s.
INDEP-INT mean 1.5 (0.8) 1.3 (0.7) 1.24 n.s.
The figures in parentheses are SD.
* p ! 0.05, ** p ! 0.01.
Table 5. Qualitative comparisons of total distress scores between
CFS/FM and MS/RA patients
TOT personal functioning CFS/FM 1 MS/RA (p = 0.0005)
social life CFS/FM 1 MS/RA (p = 0.0008)
professional life CFS/FM 1 MS/RA (p = 0.0009)
confrontations CFS/FM 1 MS/RA (p = 0.0071)
general stress CFS/FM 1 MS/RA (p = 0.01)
social developments MS/RA 1 CFS/FM (p = 0.0001)
Table 6. Correlations between duration of symptoms and EPCL sub-










F = Correlates with; * p ! 0.05, *** p ! 0.001, **** p ! 0.0001.
In contrast, among MS/RA patients, only one person-
independent item is mentioned by more that 50%: ‘cer-
tain items in the news concerned you’, whereas all other
items are mentioned at much lower frequencies.
Comparing TOT scores of CFS/FM patients with those
of the control group (table 5), CFS/FM patients show
higher distress for personal functioning [t(227) = 3.54; p =
0.0005], characterised by the following items: ‘you failed
to accomplish tasks that you thought you were capable of
doing’ [¯2(4) = 19.93; C = 0.30; p = 0.0005], ‘you were in a
state of insecurity’ [¯2(4) = 17.05; C = 0.27; p = 0.0019],
‘you could not be yourself’ [¯2(3) = 12.73; C = 0.24; p =
0.0053] and ‘you were dissatisfied with your looks’ [¯2(4) =
10.92; C = 0.22; p = 0.028].
CFS/FM patients are also more distressed in social life
[t(120.8) = 3.44; p = 0.0008], illustrated by: ‘you had to bid
farewell to a good colleague, friend or acquaintance due to
a change of job, a move or a trip’ [¯2(4) = 14.60; C = 0.25; p
= 0.0056], ‘people around you did not respect you’ [¯2(4) =
11.62; C = 0.23; p = 0.020] and ‘certain people did not
consider your feelings [¯2(4) = 9.67; C = 0.21; p = 0.046].
Furthermore, CFS/FM patients experience more dis-
tress in professional life [t(118.3) = 3.42; p = 0.0009], illus-
trated by: ‘you were not able to complete a certain task to
your satisfaction’ [¯2(4) = 11.252; C = 0.22; p = 0.021], in
confrontations [t(125.8) = 2.74; p = 0.0071], illustrated
by: ‘you were confronted with preconceptions or discrimi-
nation’ [¯2(3) = 8.02; C = 0.22; p = 0.021], and in general
stress situations [t(119.7) = 3.08; p = 0.01], illustrated by:
‘certain developments did not proceed according to plan’
[¯2(4) = 10.43; C = 0.21; p = 0.034].
It may be concluded that the majority of CFS/FM
patients feel deeply frustrated and insecure about their
own functioning as well as their social and professional
relationships. In contrast, MS/RA patients are only signif-
icantly more distressed by social developments [t(227) =
3.99; p = 0.0001], illustrated by person-independent items
such as: ‘you did not approve of certain political develop-
ments or decisions’ [¯2(4) = 23.32; C = 0.34; p = 0.00001]
and ‘certain events in the news concerned you’ [¯2(4) =
18.64; C = 0.29; p = 0.0009].
Correlations between Daily Hassles and Duration of
Symptoms
In CFS/FM patients, the subgroup of CFS/FM patients
with symptoms existing less than 12 months and the sub-
group with symptoms existing for a longer period do not
show any difference on the EPCL subscales. In contrast,
MS/RA patients with a longer duration of symptoms (12
months and more) show a higher FREQ, t(38.3) = 4.51,
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p = 0.0001 and DEP-FREQ, t(40.9) = 3.71, p = 0.0006, as
well as a higher TOT, t(35.9) = 3.55, p = 0.0011 and DEP-
TOT t(30.9) = 2.81, p = 0.0086 (table 6).
Discussion
The main goal of the present study was to obtain
insight into the frequency, emotional impact and nature
of daily hassles in recently diagnosed CFS and FM
patients, compared with patients with a recently diag-
nosed chronic organic disease.
It was found that CFS/FM patients struggle with signif-
icantly more hassles than the control group. CFS/FM
patients’ hassles are also associated with a higher degree of
emotional distress. Additionally, female CFS/FM pa-
tients report more hassles than men and seem, to a certain
degree, also more emotionally affected.
Moreover, the nature of CFS/FM patients’ hassles is
clearly different from those of the control group, i.e., they
are much more person-dependent and mainly refer to 3
major themes: (1) dissatisfaction with oneself, (2) feelings
of insecurity and (3) insufficient social recognition. In
contrast, MS/RA patients mention hassles that are mainly
person independent, more heterogeneous and comparable
with the norm group of healthy subjects [32], with the
exception of sleep disturbances. In fact, the triangle ‘dis-
satisfaction – insecurity – lack of social recognition’ is not
present at all in MS/RA patients.
Finally, the frequency of daily hassles and associated
distress increase with the duration of symptoms in MS/
RA patients, while this increase is remarkably absent in
CFS/FM patients.
Trying to interpret the above results, two possibilities
arise. First, it could be that CFS/FM patients are more
preoccupied with hassles related to personal deficiency
because they have higher levels of fatigue and pain. Also,
given the uncertainties surrounding their illness, CFS/FM
patients could be more focused on hassles related to inse-
curity. However, the control group, despite experiencing
fatigue and pain as well, and being confronted with – even
greater – uncertainty about future loss of function, seems
far less impressed by the person-dependent problems that
are in the midst of CFS/FM patients’ preoccupations.
Furthermore, CFS/FM patients’ worries about social
recognition could refer to their feeling ‘not being taken
seriously’. Many CFS and FM patients suffer indeed from
incomprehension and dismissive reactions from their en-
vironment, while this is usually not the case in MS/RA
patients. Nonetheless, symptoms of MS/RA may long be
similarly vague, exposing at least some of them to disbe-
lief as well.
A second interpretation, therefore, could be that CFS/
FM patients – in contrast to MS/RA patients – fail to
adapt to their daily worries and concerns because the lat-
ter might refer to the core of their illness experience. CFS/
FM patients’ preoccupations may, notably, reflect deep
disappointment and frustration about their failed striv-
ings for physical or mental achievement, as well as
approval from others. Such strivings – which have been
described as a central theme in the illness narratives of
CFS/FM patients [37] – may be psychodynamically
linked to personality factors, such as a vulnerable self-
esteem [38–40], narcissistic or perfectionistic tendencies
[41, 42] and, not uncommonly, early victimisation experi-
ences [14, 15].
The manifestly higher levels of depression and anxiety
in the CFS/FM group could fit into both interpretations.
On the other hand, support for the second interpretation
is provided by the fact that all CFS/FM patients show a
similar amount of hassles and distress, irrespective of the
duration of symptoms. In contrast, MS/RA patients with
a longer duration of symptoms report more (and particu-
larly more person-dependent) hassles and distress, sug-
gesting that the latter may be linked to a deterioration of
the illness. However, our results do not allow causal infer-
ences, since the duration of symptoms largely goes beyond
the period covered by the EPCL questionnaire.
In any case, these findings may have important thera-
peutic implications. They notably suggest that treatment
approaches should pay sufficient attention to CFS/FM
patients’ struggle with a multitude of daily hassles that
severely impact their self-image and lay a heavy burden
on their personal, professional and social functioning.
This would imply that psycho-educational, cognitive-
behavioural and ‘graded activity’ treatments [43–45]
should in many cases be complemented with experiential
or psychodynamically-oriented therapeutic strategies [46,
47] – not only to support the patients’ coping with symp-
toms and functional limitations, but also to help them
adapt to changing ambitions and life goals.
Limitations
The results of this study should be interpreted within
the context of several methodological limitations.
First, all CFS and FM patients were seen in tertiary
care, implying a selection bias that requires some caution
in generalising the results to a broader patient population.
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Second, despite the fact that all CFS/FM and MS/RA
in our study were characterised by similar symptoms and
lacked visible signs of disease, the associated disability in
the two groups might have been different. Whether this
could have influenced our results cannot be determined,
since no disability measures were used.
Third, both groups were not investigated at exactly the
same time after diagnosis. This could have biased our
results because both groups might have been in a different
stage of coping and adaptation (i.e., after 2 months, the
patients could be in an emotional crisis, whereas after 6
months, this crisis might be less pronounced).
Finally, the differences in mean illness duration be-
tween the groups (35.5 vs. 50.4 months) and, as men-
tioned in the previous section, the higher levels of fatigue,
pain, depression and anxiety in the CFS/FM group could
be considered confounding factors as well.
Conclusions
Within the above limitations, this study demonstrates
that recently diagnosed CFS or FM patients are over-
whelmed by person-dependent daily hassles and emotion-
al distress, focused on dissatisfaction with themselves,
feelings of insecurity and lack of social recognition. Al-
though such experiences and concerns might be linked
with personality factors increasing vulnerability to CFS
and FM, prospective research is necessary to disentangle
the complex cause/effect interactions between stress,
symptoms and disability in these patients. Treatment
should, in any case, pay sufficient attention to the severe
personal, social and professional burden these patients are
confronted with, to help them cope and facilitate long-
term adaptation.
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